CODXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:28):

Stats
本日の出来高	102 832
平均出来高	56 366.00
時価総額	37.20M
EPS	$0 ( 2024-03-14 )
次の収益日	( $-0.210 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.990
ATR14	$0.0180 (1.51%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Abbott Richard David	Buy	0	Common Stock
2024-03-15	Abbott Richard David	Buy	0	Common Stock
2024-03-15	Abbott Richard David	Buy	83 251	Common Stock Purchase Warrants
2024-03-15	Abbott Richard David	Sell	50 438	Restricted Stock Units
2023-11-23	Durenard Eugene	Sell	30 000	Restricted Stock Unit

INSIDER POWER
27.00
Last 96 transactions
Buy: 3 281 333 \| Sell: 1 334 875

Co-Diagnostics Inc 相関

10 最も正の相関
FLNT	0.981
FFWM	0.976
TOI	0.972
FSEA	0.969
MRBK	0.969
ESPR	0.963
CASA	0.963
PFSW	0.963
PTVE	0.963
PACW	0.962

10 最も負の相関
SUMO	-0.974
DSPG	-0.96
DRNA	-0.952
STAY	-0.949
PPD	-0.94
MMAC	-0.938
SMED	-0.935
NVCN	-0.935
AMRB	-0.934
FTIV	-0.933

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Co-Diagnostics Inc 財務諸表

Annual	2023
収益:	$991 473
総利益:	$-4.42M (-446.20 %)
EPS:	$-1.200

FY	2023
収益:	$991 473
総利益:	$-4.42M (-446.20 %)
EPS:	$-1.200

FY	2022
収益:	$34.22M
総利益:	$28.74M (83.98 %)
EPS:	$-0.450

FY	2021
収益:	$97.89M
総利益:	$86.31M (88.18 %)
EPS:	$1.270

Financial Reports:

No articles found.

Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.